院内心脏骤停中骨内与静脉复苏途径对结局的影响:一项回顾性研究
该单中心回顾性队列分析纳入1039例成人非创伤性院内心脏骤停患者,比较骨内(IO)与外周静脉(PIV)复苏途径。IO组出院存活率(20.8% vs 28.4%,p=0.03)和良好神经功能存活率(18.4% vs 25.2%,p=0.04)在未调整分析中较低,但多变量调整后无显著差异(OR 0.71,95%CI 0.47-1.06;OR 0.74,95%CI 0.49-1.13)。IO组自主循环恢复率更低(72.2% vs 80.7%),恢复时间更长(12:38 min vs 9:01 min),且调整后仍显著。BMI≥30 kg/m2亚组未见IO获益或损害。
要点
- 院内心脏骤停时,IO通路较PIV与更低的ROSC率相关(72.2% vs 80.7%),且TTR更长(12:38 min vs 9:01 min)。
- 多变量调整后,IO与PIV在出院存活率(OR 0.71,95%CI 0.47-1.06,p=0.09)和良好神经功能存活率(OR 0.74,95%CI 0.49-1.13,p=0.16)上无显著差异。
- 在BMI≥30 kg/m2的肥胖患者亚组中,IO与PIV相比未见获益或损害。
- 未调整分析中IO组出院存活率较低(20.8% vs 28.4%,p=0.03),良好神经功能存活率较低(18.4% vs 25.2%,p=0.04)。
- 该研究为单中心回顾性设计,IO组样本量较小(207例),结果需前瞻性研究验证。
适用人群与场景
- 成人(原文未提及具体年龄界值)非创伤性院内心脏骤停患者,来自单中心三级医疗中心。
- 排除标准原文未明确列出。
- 亚组分析纳入BMI≥30 kg/m2的患者。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:单中心回顾性队列分析;样本量:1039例符合标准(总1852例有完整数据);人群:成人非创伤性IHCA;干预:IO vs PIV复苏;主要终点:出院存活率,未调整IO vs PIV为20.8% vs 28.4%(p=0.03),多变量调整后OR 0.71(95%CI 0.47-1.06,p=0.09)。
- 关键次要终点:良好神经功能存活率未调整18.4% vs 25.2%(p=0.04),调整后OR 0.74(95%CI 0.49-1.13,p=0.16);ROSC率IO组72.2% vs PIV组80.7%,调整后仍显著更差;TTR IO组12:38 min vs PIV组9:01 min,调整后仍显著更长。
- 亚组:BMI≥30 kg/m2患者中IO与PIV相比未见获益或损害。
证据类型、等级与局限
- 证据类型:回顾性队列研究;证据等级/推荐强度原文未提及;局限:单中心、回顾性设计、IO组样本量较小(207例),可能存在选择偏倚和混杂。
对床旁实践的改变
- 在院内心脏骤停复苏时,选择IO通路可能需权衡其与PIV相比更低的ROSC率和更长的ROSC时间,但出院存活率无显著差异。
- 对于BMI≥30 kg/m2的肥胖患者,IO与PIV相比未见获益或损害,选择通路时可参考此信息。
- 该研究为回顾性设计,不能推断因果关系,临床决策应结合具体场景。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To compare outcomes between Intraosseous (IO) and peripheral intravenous (PIV) injection during in-hospital cardiac arrest (IHCA) and examine its utility in individuals with obesity.
METHODS: We performed a retrospective cohort analysis of adult, atraumatic IHCA at a single tertiary care center. Subjects were classified as either IO or PIV resuscitation. The primary outcome of interest was survival to hospital discharge. The secondary outcomes of interest were survival with favourable neurologic status, rates-of-ROSC (ROR) and time-to-ROSC (TTR). Subgroup analysis among patients with BMI ≥ 30 kg/m2 was performed.
RESULTS: Complete data were available for 1852 subjects, 1039 of whom met eligibility criteria. A total of 832 were resuscitated via PIV route and 207 via IO route. Use of IO compared to PIV was associated with lower overall survival to hospital discharge (20.8% vs 28.4% p = 0.03), lower rates of survival with favourable neurologic status (18.4% vs 25.2% p = 0.04), lower ROR (72.2% vs 80.7%) and longer TTR (12:38 min vs 9:01 min). After multivariate adjustment there was no significant differences between IO and PIV in rates of survival to discharge (OR 0.71, 95% CI 0.47-1.06, p = 0.09) or rates of survival with favourable neurologic status (OR 0.74, 95% CI 0.49-1.13, p = 0.16). The ROR and TTR remained significantly worse in the IO group. Subgroup analysis of patients with BMI ≥ 30 kg/m2 identified no benefit or harm with use of IO compared to PIV.
CONCLUSION: Intraosseous medication delivery is associated with inferior rates-of-ROSC and longer times-to-ROSC compared to PIV, but no differences in overall survival to hospital discharge or survival with favourable neurologic status during IHCA.
参考来源
- Schwalbach KT, Yong SS, Chad Wade R, et al. Impact of intraosseous versus intravenous resuscitation during in-hospital cardiac arrest: A retrospective study. Resuscitation. 2021. PMID: 34273470. doi:10.1016/j.resuscitation.2021.07.005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。